Accession Number: | 0001179110-20-009587 |
Date: | 2020-09-03 |
Issuer: | STRONGBRIDGE BIOPHARMA PLC (SBBP) |
Original Submission Date: |
GILL DAVID N
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE, PA 19053
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-09-03 | F | 23,104 | d | $3.61 | 66,896 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares withheld by strongbridge biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units. |